| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,753 | 49,152 | 49,160 | 49,162 | | Cost of Revenue | (10,851) | 10,851 |
-
| 6,768 | | | Gross Profit | 60,604 | 38,301 | 49,160 | 42,394 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,425 | (2,267) | 8,512 | 2,711 | | Non Recurring | 89 |
-
| 70 | (368) | | Others | 11,093 | 10,990 | 10,931 | 14,953 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,997 | 29,578 | 29,647 | 25,098 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,688 | (18) | 4,538 | 52 | | Earnings Before Interest And Taxes | 30,999 | 29,560 | 34,185 | 25,150 | | Interest Expense | 9,861 | 9,738 | 9,273 | 9,441 | | Income Before Tax | 21,138 | 19,822 | 24,912 | 15,709 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,138 | 19,822 | 24,912 | 15,709 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,138 | 19,822 | 24,912 | 15,709 | | Preferred Stock And Other Adjustments | (2,271) | (2,272) | (2,271) | (144) | | | Net Income Applicable To Common Shares | $18,867 | $17,550 | $22,641 | $15,565 |
|
0.03% Nasdaq 
Income Statement
